Letter from the Editor EditorProf. Hans-Peter Hartung , Heinrich Heine University, Düsseldorf, Germany ConferenceAAN 2023 26 June 2023 19:19
AAN 2023 Highlights Podcast Presented ByRobert van den Heuvel, Medicom ConferenceAAN 2023 14 May 2023 19:44
Positive results for hereditary transthyretin-mediated amyloid polyneuropathy ExpertProf. Sami Khella, University of Pennsylvania, PA, USA TrialPhase 3, NEURO-TTRansform ConferenceAAN 2023 26 April 2023 14:01
Original antigenic sin influences humoral immune response to SARS-CoV-2 ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 19:36
Allogenic T-cell-based immunotherapy for PML in development Presented ByDr George Ambalathingal, QIMR Berghofer Medical Research Institute, Australia TrialPhase 2, CE-VST01-JC ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 19:32
Lecanemab may slow decline of cognition and function in Alzheimer’s Disease Presented ByProf. Christopher van Dyck, Yale School of Medicine, CT, USA TrialPhase 3, CLARITY AD ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 19:44
Donanemab shows rapid and deep plaque clearance in early Alzheimer’s Disease Presented ByProf. Stephen Salloway, Warren Alpert Medical School of Brown University, RI, USA TrialPhase 3, TRAILBLAZER-ALZ 4 ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 19:38
Seizure forecasting and detection with wearable devices are feasible Presented ByDr Benjamin Brinkmann, Mayo Clinic, MI, USA TrialMy Seizure Gauge ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 19:56
Encouraging first results of GABAergic interneurons implants for focal epilepsy Presented ByProf. David Spencer, Oregon Health & Science University, OR, USA TrialPhase 1/2, NTRX-1001 GABAergic interneuron cell therapy ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 19:50
Lecture on migraine: from the prodromal phase to future paradigm shifts Presented ByProf. Peter Goadsby, King's College London, UK ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:24
Zavegepant nasal spray exhibits good efficacy and safety in acute migraine Presented ByProf. Richard Lipton, Albert Einstein College of Medicine, NY, USA TrialPhase 3 ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:18
Atogepant helps prevent treatment-resistant episodic migraine TrialELEVATE ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:13
Simultaneous head-to-head comparison of 25 migraine medications ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:10
A vaccine as a potentially safe and effective immunotherapy against CGRP Presented ByDr Jean-Cosme Dodart, Vaxxinity Inc, FL, USA TrialPhase 1, UB-313 ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:04
Transcriptome data predicts long-term outcomes in untreated PPMS patients TrialORATORIO ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:42
Teriflunomide prevents conversion to MS in patients with RIS Presented ByProf. Christine Lebrun-Frenay, Centre Hospitalier Universitaire de Nice, France TrialPhase 3, TERIS ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:39
Positive 4-year efficacy and safety data of ocrelizumab in early MS TrialPhase 3, ENSEMBLE ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:36
Gold nanocrystals may be effective as adjunctive MS therapy Presented ByProf. Michael Barnett, University of Sydney, Australia TrialPhase 2, VISIONARY-MS ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:33
Stem cell therapy fails primary endpoint but improves walking in more advanced progressive MS TrialPhase 2 ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:30
Ravulizumab effective in AQP4+ NMOSD Presented ByDr Sean Pittock, Mayo Clinic, NY, USA TrialPhase 3, CHAMPION-NMOSD ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:28
First-ever ALS platform trial reports on outcomes of 4 treatments Presented ByProf. Sabrina Paganoni, Massachusetts General Hospital, MA, USA TrialHEALEY ALS Platform Trial ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:49
Pridopidine for Huntington’s disease fails to meet the primary endpoint Presented ByProf. Andrew Feigin, NYU Grossman School of Medicine, NY, USA TrialPhase 3, PROOF-HD ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:46
Continuous levodopa/carbidopa infusion shows favourable safety and efficacy Presented ByDr Aaron Ellenbogen, Michigan Institute for Neurological Disorders, MI, USA TrialPhase 2, BeyoND ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:54
Unilateral right STN-DBS improves verbal fluency Presented ByDr Victor del Bene, University of Alabama, AL, USA TrialSUNDIAL ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:52
Harnessing the microbiome as a possible stroke treatment Presented ByProf. Louise McCullough, University of Texas Health Science Center, TX, USA ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 21:00
Patients with a large core infarct benefit from thrombectomy Presented ByDr Amrou Sarraj, UH Cleveland Medical Center, OH, USA TrialPhase 3, SELECT2 ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 20:57
Artificial intelligence applications in neurology: seize the moment Presented ByProf. Kathryn Davis, Penn Medicine, PA, USA ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 21:10
Spinal cord stimulation eases painful diabetic neuropathy Presented ByDr Erika Petersen, University of Arkansas, AR, USA TrialSENZA-PDN ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 21:08
EVT improves functional outcomes in Chinese patients with BAO Presented ByProf. Raul Nogueira, Grady Memorial Hospital, GA, USA TrialATTENTION ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 21:05
Severe sleep apnoea associated with white matter hyperintensities Presented ByDr Diego Carvalho, Mayo Clinic, MN, USA ConferenceAAN 2023 TypePeer-reviewed article 26 June 2023 21:03